Proton pump inhibitors and gastritis

Journal of Clinical Biochemistry and Nutrition

Volumn 42, Issue 2, 2008, Pages 71-75

  Suzuki, Masayuki ^a   Suzuki, Hidekazu ^b   Hibi, Toshifumi ^b  

^a NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastritis; Helicobacter pylori; Leukocyte; Osteoclast; Vacuolar H+ ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BAFILOMYCIN A1; CD11B ANTIGEN; CD18 ANTIGEN; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; TRITIUM; VACUOLAR TYPE ADENOSINE TRIPHOSPHATASE;

ATROPHIC GASTRITIS; AUTORADIOGRAPHY; CELL ADHESION; CELL FUNCTION; CELL GRANULE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; ENZYME ACTIVITY; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HYPERGASTRINEMIA; LEUKOCYTE; LYSOSOME; METAPLASIA; NEUTROPHIL CHEMOTAXIS; OSTEOCLAST; OXIDATIVE STRESS; REVIEW; STOMACH ACID SECRETION; STOMACH MUCOSA; STOMACH PARIETAL CELL; STOMACH PH; VASCULAR ENDOTHELIUM;

HELICOBACTER PYLORI;

EID: 46249129416     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.2008012     Document Type: Review

References (27)

1. Wandall, J.H.: Effects of omeprazole on neutrophil chemotaxis, superoxide production, degranulation and translocation of cytochrome b-245. Gut, 33, 617-621, 1992.
2. Suzuki, M., Nakamura, M., Mori, M., Miura, S., Tsuchiya, M., and Ishii, H.: Lansoprazole inhibites oxygen-derived free radical production from neutrophils activated by Helico-bacter pylori. J. Clin. Gastroenterol., 20, S93-S96, 1995.
3. Suzuki, M., Mori, M., Fukumura, D., Suzuki, H., Miura, S., and Ishii, H.: Omeprazole attenuates neutrophil-endothelial cell adhesive interaction induced by extract of Helicobacter pylori. J. Gastroenterol. Hepatol., 14, 27-31, 1999.
4. Yoshida, N., Yoshikawa, T., Tanaka, Y., Fujita, N., Kassai, K., Naito, Y., and Kondo, M.: A new mechanism for anti-inflammatory actions of proton pump inhibitors - inhibitory effects on neutrophil-endothelial cell interactions. Aliment. Pharmacol. Ther., 14 Suppl 1, 74-81, 2000.
5. Suzuki, M., Mori, M., Miura, S., Suematsu, M., Fukumura, D., Kimura, H., and Ishii, H.: Omeprazole attenuates oxygen-derived free radical production from human neutrophils. Free Radical Biol. Med., 21, 727-731, 1996.
6. Canani, R.B., Cirillo, P., Roggero, P., Romano, C., Malamisura, B., Terrin, G., Passariello, A., Manguso, F., Morelli, L., and Guarino, A.: Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics, 117, e817-e820, 2006.
7. +-ATPases. Proc. Natl. Acad. Sci. USA, 89, 6258-6261, 1992.
8. +-ATPase regulates cytoplasmic pH in murine macro-phages. J. Biol. Chem., 265, 7645-7654, 1990.
9. +-ATPase. J. Cell Biol., 105, 1637-1648, 1987.
10. +-ATPase. Curr. Pharm. Des., 8, 2033-2048, 2002.
11. +-ATPase prevents bone loss in both thyroparathyroidectomized and ovarictomized rats. J. Clin. Invest., 106, 309-318, 2000.
12. +-ATPase, inhibits bone resorption in vitro. Calcif. Tissue Int., 38, 123-125, 1986.
13. +-ATPase, on bone resorption in humans. Calcif. Tissue Int., 53, 21-25, 1993.
14. Yang, Y.X., Lewis, J.D., Epstein, S., and Metz, D.C.: Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA, 24, 2947-2953, 2006.
15. Iwahi, T., Satoh, H., Nakao, M., Iwasaki, T., Yamazaki, T., Kubo, K., Tamura, T., and Imada, A.: Lansoprazole, a novel benzimidazole proton pump inhibitor, and its compounds have selective activity against Helicobacter pylori. Antimicrob. Agents Chemother., 35, 490-496, 1991.
16. Tsuchiya, M., Imamura, L., Park, J.B., and Kobayashi, K.: Helicobacter pylori urease inhibition by rabeprazole, a proton pump inhibitor. Biol. Pharm. Bull., 18, 1053-1056, 1995.
17. Graham, D.Y., Opekun, A.R., Hammoud, F., Yamaoka, Y., Reddy, R., Osato, M.S., and El-Zimaity, H.M.: Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors. Am. J. Gastroenterol., 98, 1005-1009, 2003.
18. Logan, R.P.H., Walker, M.M., Misiewicz, J.J., Gummett, P.A., Karim, Q.N., and Baron, J.H.: Changes in the intra-gastric distribution of Helicobacter pylori during treatment with omeprazole. Gut, 36, 12-16, 1995.
19. Suzuki, M., Suzuki, H., Kitahora, T., Miyazawa, M., Nagahashi, S., Suzuki, K., and Ishii, H.: Treatment with a proton pump inhibitor promotes corpus gastritis in patients with H. pylori-infected antrum-predominant gastritis. Aliment. Pharmacol. Ther., 16, 159-165, 2002.
20. Suzuki, M., Asako, H., Kubes, P., Jennings, S., Grisham, M.B., and Granger, D.N.: Neutrophil-derived oxidants promote leukocyte adherence in postcapillary venules. Microvasc. Res., 42, 125-138, 1991.
21. Kuipers, E.J., Lundell, L., Klinkenberg-Knol, E.C., Havu, N., Festen, H.P.M., Liedman, B., Lamers, C.B.H.W., Jansen, J.B.M.J., Dalenbäck, J., Snel, P., Nelis, G.F., and Meuwissen, S.G.M.: Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N. Engl. J. Med., 334, 1018-1022, 1996.
22. Suzuki, M., Suzuki, H., Kitahora, T., Miyazawa, M., Nagahashi, S., Suzuki, K., and Ishii, H.: Proton pump inhibitor modifies inflammatory reaction in human gastric mucosa infected by Helicobacter pylori. Aliment. Pharmacol. Ther., 16(s2), 229-234, 2002.
23. Suzuki, M., Tanaka, S., Suzuki, K., Kitahora, T., Masaoka, T., Suzuki, H., and Hibi, T.: Persistent oxidative stress in the corpus mucosa is evoked by long-term treatment of H. pylori-infected patients with proton pump inhibitors. Hepato-Gastroenterol., 2008 (in press).
24. Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N., and Schlemper, R.J.: Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med., 345, 784-789, 2001.
25. Isomoto, H., Nishi, Y., Kanazawa, Y., Shikuwa, S., Mizuta, Y., Inoue, K., and Kohno, S.: Immune and inflammatory responses in GERD and lansoprazole. J. Clin. Biochem. Nutr., 41, 84-91, 2007.
26. Mine, M. and Tanaka, Y: Lansoprazole-induced improvement of esophageal submucosal injury. J. Clin. Biochem. Nutr., 41, 92-96, 2007.
27. Suzuki, M., Suzuki, H., Kitahora, T., Nagahashi, S., Masaoka, T., Tanaka, S., Suzuki, K., and Ishii, H.: Helicobacter pylorieradication therapy decreases the level of neutrophil-derived oxidants in the ulcerous mucosa of the human stomach: Relationship between ulcer stage and mucosal oxidant level. Dig. Endosc., 15, 270-274, 2003.